Acetylcholinesterase inhibitors as Alzheimer therapy: from nerve toxins to neuroprotection

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics

Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864 · see citing works

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404 · see citing works

Memory systems of the brain: A brief history and current perspective

Squire, L. R. (2004) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2004.06.005 · Cited by 2,269 · see citing works

Diabetes mellitus and the risk of dementia: The Rotterdam Study

Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175 · see citing works

A Century of Alzheimer's Disease

Goedert, M., & Spillantini, M. G. (2006) · Science · doi:10.1126/science.1132814 · Cited by 2,106 · see citing works

Memantine in Moderate-to-Severe Alzheimer's Disease

Reisberg, B., Doody, R., Stöffler, A., Schmitt, F., Ferris, S., & Möbius, H. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa013128 · Cited by 2,043 · see citing works

General Nature of the Genetic Code for Proteins

Crick, F. H. C., Barnett, L., Brenner, S., & Watts-Tobin, R. J. (1961) · Nature · doi:10.1038/1921227a0 · Cited by 1,392 · see citing works

Oral Tetrahydroaminoacridine in Long-Term Treatment of Senile Dementia, Alzheimer Type

Summers, W. K., Majovski, L. V., Marsh, G. M., Tachiki, K. H., & Kling, A. S. (1986) · New England Journal of Medicine · doi:10.1056/nejm198611133152001 · Cited by 1,161 · see citing works

Microglia: Intrinsic immuneffector cell of the brain

Gehrmann, J., Matsumoto, Y., & Kreutzberg, G. W. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(94)00015-h · Cited by 1,111 · see citing works

Acetylcholinesterase Accelerates Assembly of Amyloid-β-Peptides into Alzheimer's Fibrils: Possible Role of the Peripheral Site of the Enzyme

Inestrosa, N. C., Alvarez, A. R., Pérez, C. A., Moreno, R. D., Vicente, M., Linker, C., Casanueva, O. I., Soto, C. A., & Garrido, J. (1996) · Neuron · doi:10.1016/s0896-6273(00)80108-7 · Cited by 1,107 · see citing works

The Toxins of Cyanobacteria

Carmichael, W. W. (1994) · Scientific American · doi:10.1038/scientificamerican0194-78 · Cited by 1,100 · see citing works

Acetylcholinesterase: Enzyme structure, reaction dynamics, and virtual transition states

Quinn, D. M. (1987) · Chemical Reviews · doi:10.1021/cr00081a005 · Cited by 1,072 · see citing works

Autoimmune Response to Acetylcholine Receptor

Patrick, J., & Lindstrom, J. M. (1973) · Science · doi:10.1126/science.180.4088.871 · Cited by 1,049 · see citing works

Tau pathology in Alzheimer disease and other tauopathies

Iqbal, K., del C. Alonso, A., Chen, S., Chohan, M. O., El-Akkad, E., Gong, C.-X., Khatoon, S., Li, B., Liu, F., Rahman, A., et al. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.09.008 · Cited by 1,037 · see citing works

Review Article: Genetics of Alzheimer Disease

Bekris, L. M., Yu, C.-E., Bird, T. D., & Tsuang, D. W. (2010) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988710383571 · Cited by 1,029 · see citing works

Mechanism of action of organophosphorus and carbamate insecticides.

Fukuto, T. R. (1990) · Environmental Health Perspectives · doi:10.1289/ehp.9087245 · Cited by 975 · see citing works

Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase.

Harel, M., Schalk, I. J., Ehret‐Sabatier, L., Bouet, F., Goeldner, M. P., HIRTH, C. G., Axelsen, P. H., Silman, I., & Sussman, J. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.9031 · Cited by 902 · see citing works

The Molecular Forms of Cholinesterase and Acetylcholinesterase in Vertebrates

Massoulié, J., & Bon, S. (1982) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.05.030182.000421 · Cited by 818 · see citing works

Alzheimer's Disease: Molecular Understanding Predicts Amyloid-Based Therapeutics

Selkoe, D. J., & Schenk, D. (2003) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.140248 · Cited by 816 · see citing works

Organophosphates⧸Nerve Agent Poisoning: Mechanism of Action, Diagnosis, Prophylaxis, And Treatment

Bajgar, J. (2004) · Advances in clinical chemistry · doi:10.1016/s0065-2423(04)38006-6 · Cited by 701 · see citing works

Targeting acetylcholinesterase and butyrylcholinesterase in dementia

Lane, R. M., Potkin, S. G., & Enz, A. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005833 · Cited by 654 · see citing works

ULTRASTRUCTURAL STUDIES IN ALZHEIMER'S PRESENILE DEMENTIA.

Terry, R. D., Gonatas, N. K., & WEISS, M. (1964) · PubMed · Cited by 650 · see citing works

The Prevalence and Malignancy of Alzheimer Disease

Katzman, R. (1976) · Archives of Neurology · doi:10.1001/archneur.1976.00500040001001 · Cited by 623 · see citing works

Poisoning due to organophosphate insecticides

Namba, T., Nolte, C. T., Jackrel, J., & Grob, D. (1971) · The American Journal of Medicine · doi:10.1016/0002-9343(71)90337-8 · Cited by 586 · see citing works

Medical Aspects of Chemical and Biological Warfare

Wilde, H. D. (1998) · JAMA · doi:10.1001/jama.280.13.1199 · Cited by 576 · see citing works

Organophosphorus pesticides; organic and biological chemistry

Etō, M. (1974) · Cited by 547 · see citing works

A review on coumarins as acetylcholinesterase inhibitors for Alzheimer’s disease

Anand, P., Singh, B., & Singh, N. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.12.042 · Cited by 530 · see citing works

Prevalence and Malignancy of Alzheimer Disease

Lijtmaer, H., Fuld, P. A., & Katzman, R. (1976) · Archives of Neurology · doi:10.1001/archneur.1976.00500040088017 · Cited by 517 · see citing works

Organophosphorus pesticides: Organic and biological chemistry

Hart, G. J. (1975) · Pesticide Biochemistry and Physiology · doi:10.1016/0048-3575(75)90061-9 · Cited by 501 · see citing works

Functional network disruption in the degenerative dementias

Pievani, M., de Haan, W., Wu, T., Seeley, W. W., & Frisoni, G. B. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70158-2 · Cited by 481 · see citing works

A Structural Motif of Acetylcholinesterase That Promotes Amyloid β-Peptide Fibril Formation

Ferrari, G. V. D., Canales, M. A., Shin, I., Weiner, L. M., Silman, I., & Inestrosa, N. C. (2001) · Biochemistry · doi:10.1021/bi0101392 · Cited by 415 · see citing works

Organophosphorus Ester-Induced Delayed Neurotoxicity

Abou-Donia, M. B. (1981) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.21.040181.002455 · Cited by 404 · see citing works

THE FINE STRUCTURE OF NEUROFIBRILLARY TANGLES IN ALZHEIMERʼS DISEASE

Terry, R. D. (1963) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-196310000-00005 · Cited by 403 · cited 2× · see citing works

Review of Oximes in the Antidotal Treatment of Poisoning by Organophosphorus Nerve Agents

Kassa, J. (2002) · Journal of Toxicology Clinical Toxicology · doi:10.1081/clt-120015840 · Cited by 391 · see citing works

Occupational exposure to pesticides increases the risk of incident AD

Hayden, K. M., Norton, M. C., Darcey, D. J., Østbye, T., Zandi, P. P., Breitner, J. C. S., & Welsh-Bohmer, K. A. (2010) · Neurology · doi:10.1212/wnl.0b013e3181dd4423 · Cited by 387 · see citing works

Calcium hypothesis of Alzheimer’s disease

Berridge, M. J. (2009) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-009-0736-1 · Cited by 384 · see citing works

CHOLINESTERASES, A TARGET OF PHARMACOLOGY AND TOXICOLOGY

Pohanka, M. (2011) · Biomedical Papers · doi:10.5507/bp.2011.036 · Cited by 377 · see citing works

Neurofibrillary tangles of paired helical filaments

Wı́sniewski, H. M., Narang, H. K., & Terry, R. D. (1976) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(76)90059-9 · Cited by 370 · see citing works

Interaction of fluorescence probes with acetylcholinesterase. Site and specificity of propidium binding

Taylor, P., & Lappi, S. (1975) · Biochemistry · doi:10.1021/bi00680a029 · Cited by 367 · see citing works

Acetylcholinesterase inhibitory activity of some Amaryllidaceae alkaloids and Narcissus extracts

López, S., Bastida, J., Viladomat, F., & Codina, C. J. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)02034-9 · Cited by 359 · see citing works

Highly Potent, Selective, and Low Cost Bis-tetrahydroaminacrine Inhibitors of Acetylcholinesterase

Pang, Y., Quiram, P. A., Jelacic, T. M., Hong, F., & Brimijoin, S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.39.23646 · Cited by 344 · see citing works

Linking Calcium to Aβ and Alzheimer's Disease

Green, K. N., & LaFerla, F. M. (2008) · Neuron · doi:10.1016/j.neuron.2008.07.013 · Cited by 326 · see citing works

The Peripheral Anionic Site of Acetylcholinesterase: Structure, Functions and Potential Role in Rational Drug Design

Johnson, G., & Moore, S. W. (2005) · Current Pharmaceutical Design · doi:10.2174/138161206775193127 · Cited by 322 · see citing works

Stable Complexes Involving Acetylcholinesterase and Amyloid-β Peptide Change the Biochemical Properties of the Enzyme and Increase the Neurotoxicity of Alzheimer’s Fibrils

Alvarez, A. R., Alarcón, R., Opazo, C., Campos, E. O., Muñoz, F. J., Calderón, F. H., Dajas, F., Gentry, M. K., Doctor, B. P., Mello, F. G. D., et al. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-09-03213.1998 · Cited by 320 · see citing works

Galantamine — a Novel Cholinergic Drug with a Unique Dual Mode of Action for the Treatment of Patients with Alzheimer's Disease

Lilienfeld, S. (2002) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2002.tb00221.x · Cited by 309 · see citing works

Acetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrils.

Álvarez, A., Opazo, C., Alarcón, R., Garrido, J., & Inestrosa, N. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1245 · Cited by 308 · see citing works

Chemical warfare agents: II. nerve agents

Sidell, F. R., & Borak, J. (1992) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(05)81036-4 · Cited by 288 · see citing works

Organophosphorus compounds as chemical warfare agents: a review

Delfino, R. T., Ribeiro, T. S., & Figueroa‐Villar, J. D. (2009) · Journal of the Brazilian Chemical Society · doi:10.1590/s0103-50532009000300003 · Cited by 283 · see citing works

Developing β‐secretase inhibitors for treatment of Alzheimer’s disease

Ghosh, A. K., Brindisi, M., & Tang, J. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07476.x · Cited by 272 · see citing works

New Tacrine–4-Oxo-4H-chromene Hybrids as Multifunctional Agents for the Treatment of Alzheimer’s Disease, with Cholinergic, Antioxidant, and β-Amyloid-Reducing Properties

Fernández‐Bachiller, M. I., Pérez, C., Monjas, L., Rademann, J., & Rodrı́guez-Franco, M. I. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201460y · Cited by 271 · see citing works

Multi-Target-Directed Drug Design Strategy: From a Dual Binding Site Acetylcholinesterase Inhibitor to a Trifunctional Compound against Alzheimer’s Disease

Bolognesi, M. L., Cavalli, A., Valgimigli, L., Bartolini, M., Rosini, M., Andrisano, V., Recanatini, M., & Melchiorre, C. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm701225u · Cited by 262 · see citing works

Amyloid–cholinesterase interactions

Inestrosa, N. C., Dinamarca, M. C., & Alvarez, A. R. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2007.06238.x · Cited by 261 · see citing works

Post‐synaptic potentiation: interaction between quanta of acetylcholine at the skeletal neuromuscular synapse.

Hartzell, H. C., Kuffler, S. W., & Yoshikami, D. (1975) · The Journal of Physiology · doi:10.1113/jphysiol.1975.sp011102 · Cited by 258 · see citing works

Novel Tacrine−Melatonin Hybrids as Dual-Acting Drugs for Alzheimer Disease, with Improved Acetylcholinesterase Inhibitory and Antioxidant Properties

Rodrı́guez-Franco, M. I., Fernández‐Bachiller, M. I., Pérez, C., Hernández‐Ledesma, B., & Bartolomé, B. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050746d · Cited by 250 · see citing works

Acetylcholinesterase

Rosenberry, T. L. (1975) · Advances in enzymology and related areas of molecular biology/Advances in enzymology and related subjects · doi:10.1002/9780470122884.ch3 · Cited by 249 · see citing works

Calcium Ionophore Increases Amyloid .beta. Peptide Production by Cultured Cells

Querfurth, H. W., & Selkoe, D. J. (1994) · Biochemistry · doi:10.1021/bi00181a016 · Cited by 243 · see citing works

Hydrogen Peroxide Is Generated during the Very Early Stages of Aggregation of the Amyloid Peptides Implicated in Alzheimer Disease and Familial British Dementia

Tabner, B. J., El‐Agnaf, O. M. A., Turnbull, S., German, M. J., Paleologou, K. E., Hayashi, Y., Cooper, L. J., Fullwood, N. J., & Allsop, D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500238200 · Cited by 241 · see citing works

Anatoxin-a(s), a potent anticholinesterase from Anabaena flos-aquae

Matsunaga, S., Moore, R. E., Niemczura, W. P., & Carmichael, W. W. (1989) · Journal of the American Chemical Society · doi:10.1021/ja00202a057 · Cited by 240 · see citing works

Crystal structure of an acetylcholinesterase–fasciculin complex: interaction of a three-fingered toxin from snake venom with its target

Harel, M., Kleywegt, G. J., Ravelli, R. B. G., Silman, I., & Sussman, J. L. (1995) · Structure · doi:10.1016/s0969-2126(01)00273-8 · Cited by 239 · see citing works

Introduction to insect biology and diversity

Daly, H. V., Doyen, J. T., & Ehrlich, P. R. (1978) · Cited by 230 · see citing works

Rational Approach To Discover Multipotent Anti-Alzheimer Drugs

Rosini, M., Andrisano, V., Bartolini, M., Bolognesi, M. L., Hrelia, P., Minarini, A., Tarozzi, A., & Melchiorre, C. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049112h · Cited by 228 · see citing works

Introduction to Insect Biology and Diversity

Zenger, J. T., Daly, H. V., Doyen, J. T., & Purcell, A. H. (1999) · Florida Entomologist · doi:10.2307/3495844 · Cited by 217 · see citing works

Calcium dysregulation in Alzheimer's disease

Bojarski, Ł., Herms, J. W., & Kuźnicki, J. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.10.002 · Cited by 202 · see citing works

Novel donepezil-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.

Camps, P., Formosa, X., Galdeano, C., Gómez, T., Muñoz-Torrero, D., Scarpellini, M., Viayna, E., Badía, A., Clos, M. V., Camins, A., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8001313 · Cited by 194 · see citing works

Mitochondrial Dysfunction: The First Domino in Brain Aging and Alzheimer's Disease?

Leuner, K., Hauptmann, S., Abdel-Kader, R. M., Scherping, I., Keil, U., Strosznajder, J. B., Eckert, A., & Müller, W. E. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1763 · Cited by 194 · see citing works

Mutagenesis of human acetylcholinesterase. Identification of residues involved in catalytic activity and in polypeptide folding.

Avigdor Shafferman, C., Kronman, C., Flashner, Y., Leitner, M., Grosfeld, H., Ordentlich, A., Gozes, Y., Cohen, S., Ariel, N., & Barak, D. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37091-7 · Cited by 192 · see citing works

Inhibition of Acetylcholinesterase, β-Amyloid Aggregation, and NMDA Receptors in Alzheimer’s Disease: A Promising Direction for the Multi-target-Directed Ligands Gold Rush

Rosini, M., Simoni, E., Bartolini, M., Cavalli, A., Ceccarini, L., Pascu, N., McClymont, D. W., Tarozzi, A., Bolognesi, M. L., Minarini, A., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800577j · Cited by 186 · see citing works

Tau Proteins and Neurofibrillary Degeneration

Goedert, M., Spillantini, M. G., & Crowther, R. A. (1991) · Brain Pathology · doi:10.1111/j.1750-3639.1991.tb00671.x · Cited by 178 · see citing works

Anesthesia and myasthenia gravis

Blichfeldt‐Lauridsen, L., & HANSEN, B. D. (2011) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.2011.02558.x · Cited by 170 · see citing works

CHEMICAL WARFARE

Holstege, C. P., Kirk, M., & Sidell, F. R. (1997) · Critical Care Clinics · doi:10.1016/s0749-0704(05)70374-2 · Cited by 169 · see citing works

The Nicotinic Allosteric Potentiating Ligand Galantamine Facilitates Synaptic Transmission in the Mammalian Central Nervous System

Santos, M. D., Alkondon, M., Pereira, E. F. R., Aracava, Y., Eisenberg, H. M., Maelicke, A., & Albuquerque, E. X. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.5.1222 · Cited by 169 · see citing works

Termination and beyond: acetylcholinesterase as a modulator of synaptic transmission

Zimmerman, G., & Soreq, H. (2006) · Cell and Tissue Research · doi:10.1007/s00441-006-0239-8 · Cited by 168 · see citing works

Risk factors for Alzheimer's disease and dementia

MRCPsych, M. P., FRANZCP, M. C., & MANN, A. H. (1994) · Neurology · doi:10.1212/wnl.44.1.97 · Cited by 163 · see citing works

Chemical warfare agents: Toxicology and treatment

Watson, K. D. (1997) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(97)89718-2 · Cited by 163 · see citing works

Peripheral and Dual Binding Site Acetylcholinesterase Inhibitors: Implications in treatment of Alzheimers Disease

Castro, A., & Martı́nez, A. (2001) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557013406864 · Cited by 160 · see citing works

Donepezil–tacrine hybrid related derivatives as new dual binding site inhibitors of AChE

Alonso, D. A., Dorronsoro, I., Rubio, L., Muñoz, P., García‐Palomero, E., del Monte, M., Bidon‐Chanal, A., Orozco, M., Luque, F. J., Castro, A., et al. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.09.029 · Cited by 157 · see citing works

The Pharmacology of Physostigmine

Triggle, D. J., Mitchell, J. M., & Filler, R. (1998) · CNS Drug Reviews · doi:10.1111/j.1527-3458.1998.tb00059.x · Cited by 155 · see citing works

A Textbook of Clinical Neurology.

(1947) · Archives of Internal Medicine · doi:10.1001/archinte.1947.00220170127009 · Cited by 155 · see citing works

Design, Synthesis, and Biological Evaluation of Conformationally Restricted Rivastigmine Analogues

Bolognesi, M. L., Bartolini, M., Cavalli, A., Andrisano, V., Rosini, M., Minarini, A., & Melchiorre, C. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049782n · Cited by 150 · see citing works

The role of tau phosphorylation and cleavage in neuronal cell death

Chun, W. (2006) · Frontiers in bioscience · doi:10.2741/2097 · Cited by 142 · see citing works

The role of excitotoxicity in organophosphorous nerve agents central poisoning

Solberg, Y., & Belkin, M. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)89540-5 · Cited by 140 · see citing works

The role of excitotoxicity in organophosphorous nerve agents central poisoning

Solber, Y., & Belkin, M. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)90617-9 · Cited by 131 · see citing works

Primary structures of the catalytic subunits from two molecular forms of acetylcholinesterase. A comparison of NH2-terminal and active center sequences.

MacPhee-Quigley, K., Taylor, P., & Taylor, S. S. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39005-1 · Cited by 129 · see citing works

Common structural features determine the effectiveness of carvedilol, daunomycin and rolitetracycline as inhibitors of Alzheimer beta-amyloid fibril formation.

Howlett, D. R., George, A. R., OWEN, D. E., Ward, R. V., & Markwell, R. E. (1999) · PubMed Central · Cited by 123 · see citing works

Calcium-mediated Transient Phosphorylation of Tau and Amyloid Precursor Protein Followed by Intraneuronal Amyloid-β Accumulation

Pierrot, N., Santos, S. F., Feyt, C., Morel, M., Brion, J., & Octave, J. N. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606015200 · Cited by 121 · see citing works

Common structural features determine the effectiveness of carvedilol, daunomycin and rolitetracycline as inhibitors of Alzheimer β-amyloid fibril formation

Howlett, D. R., George, A. R., OWEN, D. E., Ward, R. V., & Markwell, R. E. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3430419 · Cited by 119 · see citing works

Indole alkaloids from Tabernaemontana australis (Müell. Arg) Miers that inhibit acetylcholinesterase enzyme

Andrade, M. T., Lima, J. A., Pinto, A. C., Rezende, C. M., Carvalho, M. P., & Epifanio, R. D. A. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.03.045 · Cited by 117 · see citing works

Design, Synthesis, and Pharmacological Profile of Novel Fused Pyrazolo[4,3- d ]pyridine and Pyrazolo[3,4- b ][1,8]naphthyridine Isosteres: A New Class of Potent and Selective Acetylcholinesterase Inhibitors

Barreiro, E. J., Câmara, C. A., Verli, H., Brazil-Más, L., Castro, N. G., Cintra, W. M., Aracava, Y., Rodrigues, C. R., & Fraga, C. A. M. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020391n · Cited by 113 · see citing works

Novel Benzisoxazole Derivatives as Potent and Selective Inhibitors of Acetylcholinesterase

Villalobos, A., Blake, J. F., Bíggers, C. K., Butler, T. W., Chapin, D. S., Chen, Y. L., Ives, J. L., Jones, S. B., & Liston, D. R. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00043a012 · Cited by 112 · see citing works

Ligand binding properties of acetylcholinesterase determined with fluorescent probes

Mooser, G., & Sigman, D. S. (1974) · Biochemistry · doi:10.1021/bi00708a010 · Cited by 111 · see citing works

Further Bioactive Piperidine Alkaloids from the Flowers and Green Fruits of Cassia spectabilis

Viegas, C., Bolzani, V. D. S., Furlan, M., Barreiro, E. J., Young, M. C. M., Tomazela, D. M., & Eberlin, M. N. (2004) · Journal of Natural Products · doi:10.1021/np0303963 · Cited by 110 · see citing works

Neuroprotective and Cholinergic Properties of Multifunctional Glutamic Acid Derivatives for the Treatment of Alzheimer’s Disease

Arce, M. P., Rodrı́guez-Franco, M. I., González-Muñoz, G. C., Pérez, C., López, B., Villarroya, M., López, M. G., Garcı́a, A. G., & Conde, S. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900628z · Cited by 109 · see citing works

Synthesis of Tricyclic 1,3-Oxazin-4-ones and Kinetic Analysis of Cholesterol Esterase and Acetylcholinesterase Inhibition

Pietsch, M., & Gütschow, M. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0508639 · Cited by 106 · see citing works

Progress in Clinical, Pharmacological, Chemical and Structural Biological Studies of Huperzine A: A Drug of Traditional Chinese Medicine Origin for the Treatment of Alzheimers Disease

Jiang, H., Luo, X., & Bai, D. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033456747 · Cited by 106 · see citing works

Galangin, a flavonol derived from Rhizoma Alpiniae Officinarum, inhibits acetylcholinesterase activity in vitro

Guo, A. J. Y., Xie, H. Q., Choi, R. C. Y., Zheng, Y., Bi, C. W. C., Xu, S. L., Dong, T. T.-X., & Tsim, K. W. K. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.05.002 · Cited by 104 · see citing works

Homobivalent Quinazolinimines as Novel Nanomolar Inhibitors of Cholinesterases with Dirigible Selectivity toward Butyrylcholinesterase

Decker, M. W. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060682m · Cited by 101 · see citing works

Targeting Alzheimer’s disease: Novel indanone hybrids bearing a pharmacophoric fragment of AP2238

Rizzo, S., Bartolini, M., Ceccarini, L., Piazzi, L., Gobbi, S., Cavalli, A., Recanatini, M., Andrisano, V., & Rampa, A. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.01.071 · Cited by 99 · see citing works

Synthesis, biological evaluation, and molecular modeling of berberine derivatives as potent acetylcholinesterase inhibitors

Huang, L., Shi, A., He, F., & Li, X. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.12.035 · Cited by 94 · see citing works

A Higher Form of Killing: The Secret Story of Chemical and Biological Warfare

Harris, R., & Paxman, J. (1982) · Virtual Defense Library (Ministerio de Defensa) · Cited by 93 · see citing works

Synthesis, biological evaluation and molecular modelling of diversely functionalized heterocyclic derivatives as inhibitors of acetylcholinesterase/butyrylcholinesterase and modulators of Ca2+ channels and nicotinic receptors

Marco, J. L., Rı́os, C. D. L., Garcı́a, A. G., Villarroya, M., Carreiras, M. C., Martins, C., Eleutério, A., Morreale, A., Orozco, M., & Luque, F. J. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.02.017 · Cited by 91 · see citing works

Contemporary Anticholinesterase Pharmaceuticals of Natural Origin and Their Synthetic Analogues for the Treatment of Alzheimers Disease

Orhan, G., Orhan, I., Subutay-Oztekin, N., Ak, F., & Sener, B. (2009) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488909787002582 · Cited by 90 · see citing works

Cholinesterase Inhibitors: Xanthostigmine Derivatives Blocking the Acetylcholinesterase-Induced β-Amyloid Aggregation

Belluti, F., Rampa, A., Piazzi, L., Bisi, A., Gobbi, S., Bartolini, M., Andrisano, V., Cavalli, A., Recanatini, M., & Valenti, P. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049515h · Cited by 87 · see citing works

Fluorescence energy transfer on acetylcholinesterase: spatial relationship between peripheral site and active center

Berman, H. A., Yguerabide, J., & Taylor, P. (1980) · Biochemistry · doi:10.1021/bi00551a036 · Cited by 86 · see citing works

Novel tricyclic quinazolinimines and related tetracyclic nitrogen bridgehead compounds as cholinesterase inhibitors with selectivity towards butyrylcholinesterase

Decker, M. W., Krauth, F., & Lehmann, J. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.10.044 · Cited by 85 · see citing works

Histopathology and APOE genotype of the first Alzheimer disease patient, Auguste D.

Graeber, M. B., Kösel, S., Grasbon-Frodl, E. M., Möller, H. ‐., & Mehraein, P. (1998) · Neurogenetics · doi:10.1007/s100480050033 · Cited by 82 · see citing works

Clinical effects of organophosphorus cholinesterase inhibitors

Sidell, F. R. (1994) · Journal of Applied Toxicology · doi:10.1002/jat.2550140212 · Cited by 80 · see citing works

Synthesis and evaluation of tacrine–Huperzine a hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of alzheimer’s disease

Badı́a, A., Baños, J.-E., Camps, P., Contreras, J., GOERBIG, D. M., Muñoz‐Torrero, D., Simón, M., & Vivas, N. M. (1998) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(98)00015-7 · Cited by 80 · see citing works

N-Benzylpiperidine derivatives of 1,2,4-thiadiazolidinone as new acetylcholinesterase inhibitors

Martı́nez, A., Fernandez, E., Castro, A., Conde, S., Rodrı́guez-Franco, M. I., Baños, J.-E., & Badı́a, A. (2000) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(00)01166-1 · Cited by 79 · see citing works

Methyl Analogues of the Experimental Alzheimer Drug Phenserine: Synthesis and Structure/Activity Relationships for Acetyl- and Butyrylcholinesterase Inhibitory Action

Yu, Q., Holloway, H. W., Flippen-Anderson, J. L., Hoffman, B., Brossi, A. R., & Greig, N. H. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010080x · Cited by 79 · see citing works

Synthesis, biological evaluation and molecular modeling of oxoisoaporphine and oxoaporphine derivatives as new dual inhibitors of acetylcholinesterase/butyrylcholinesterase

Tang, H., Wei, Y., Zhang, C., Ning, F.-X., Qiao, W., Huang, S., Ma, L., Huang, Z., & Gu, L. (2009) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2009.01.021 · Cited by 75 · see citing works

Acetylcholinesterase: C-terminal domains, molecular forms and functional localization

Massoulié, J., Anselmet, A., Bon, S., Krejci, É., Legay, C., Morel, N., & Simon, S. (1998) · Journal of Physiology-Paris · doi:10.1016/s0928-4257(98)80007-7 · Cited by 73 · see citing works

Metrifonate for Alzheimer's disease

López-Arrieta, J., & Schneider, L. S. S. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003155.pub3 · Cited by 72 · see citing works

Design, synthesis and evaluation of galanthamine derivatives as acetylcholinesterase inhibitors

Jia, P. J., Sheng, R., Zhang, J., Fang, L., He, Q., Yang, B., & Hu, Y. (2008) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.04.018 · Cited by 70 · see citing works

Synthesis and Pharmacological Evaluation of Huprine−Tacrine Heterodimers: Subnanomolar Dual Binding Site Acetylcholinesterase Inhibitors

Camps, P., Formosa, X., Muñoz‐Torrero, D., Pétrignet, J., Badı́a, A., & Clos, M. V. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0496741 · Cited by 70 · see citing works

Hybrids of oxoisoaporphine-tacrine congeners: Novel acetylcholinesterase and acetylcholinesterase-induced β-amyloid aggregation inhibitors

Tang, H., Zhao, L.-Z., Zhao, H., Huang, S., Zhong, S., Qin, J., Chen, Z., Huang, Z., & Liang, H. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.08.002 · Cited by 68 · see citing works

Cognitive Deficits in the Early Stages of Alzheimer's Disease

Storandt, M. (2008) · Current Directions in Psychological Science · doi:10.1111/j.1467-8721.2008.00574.x · Cited by 68 · see citing works

Cholinesterase inhibitors: SAR and enzyme inhibitory activity of 3-[ω-(benzylmethylamino)alkoxy]xanthen-9-ones

Piazzi, L., Belluti, F., Bisi, A., Gobbi, S., Rizzo, S., Bartolini, M., Andrisano, V., Recanatini, M., & Rampa, A. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.09.026 · Cited by 67 · see citing works

Bioactive and other piperidine alkaloids from Cassia leptophylla

Bolzani, V. D. S., Gunatilaka, A. A. L., & Kingston, D. G. I. (1995) · Tetrahedron · doi:10.1016/0040-4020(95)00254-6 · Cited by 67 · see citing works

Synthesis and Screening for Antiacetylcholinesterase Activity of (1-Benzyl-4-oxopiperidin-3-ylidene)methylindoles and -pyrroles Related to Donepezil

Andreani, A., Cavalli, A., Granaiola, M., Guardigli, M., Leoni, A., Locatelli, A., Morigi, R., Rambaldi, M., Recanatini, M., & Roda, A. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0109356 · Cited by 66 · see citing works

Synthesis and in vitro evaluation of N-alkyl-7-methoxytacrine hydrochlorides as potential cholinesterase inhibitors in Alzheimer disease

Korábečný, J., Musílek, K., Holas, O., Binder, J., Zemek, F., Marek, J., Pohanka, M., Opletalová, V., Dohnal, V., & Kuča, K. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.08.044 · Cited by 65 · see citing works

New selective acetylcholinesterase inhibitors designed from natural piperidine alkaloids

Viegas, C., Bolzani, V. D. S., Pimentel, L. S. B., Castro, N. G., Cabral, R. F., da Costa, R. S., Floyd, C., Rocha, M. S., Young, M. C. M., Barreiro, E. J., et al. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.04.030 · Cited by 64 · see citing works

Protein Tau: Prime Cause of Synaptic and Neuronal Degeneration in Alzheimer's Disease

Crespo‐Biel, N., Theunis, C., & LEUVEN, F. V. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/251426 · Cited by 64 · see citing works

Alzheimer's Disease

Wilkins, R. H., & Brody, I. A. (1969) · Archives of Neurology · doi:10.1001/archneur.1969.00480130123013 · Cited by 64 · see citing works

Synthesis and acetylcholinesterase/butyrylcholinesterase inhibition activity of new tacrine-like analogues

Marco, J. L., Rı́os, C. D. L., Carreiras, M. C., Baños, J.-E., Badı́a, A., & Vivas, N. M. (2001) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(00)00284-4 · Cited by 63 · see citing works

Design, synthesis, and evaluation of 2-phenoxy-indan-1-one derivatives as acetylcholinesterase inhibitors

Sheng, R., Lin, X., Li, J., Jiang, Y., Shang, Z., & Hu, Y. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.05.132 · Cited by 63 · see citing works

Further Studies on the Interaction of the 5-Hydroxytryptamine3(5-HT3) Receptor with Arylpiperazine Ligands. Development of a New 5-HT3Receptor Ligand Showing Potent Acetylcholinesterase Inhibitory Properties

Cappelli, A., Gallelli, A., Manini, M., Anzini, M., Mennuni, L., Makovec, F., Menziani, M. C., Alcaro, S., Ortuso, F., & Vomero, S. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0493461 · Cited by 62 · see citing works

Differential effects of "peripheral" site ligands on Torpedo and chicken acetylcholinesterase.

Eichler, J., Anselment, A., Sussman, J. L., Massoulié, J., & Silman, I. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09933-x · Cited by 62 · see citing works

Kinetics and structure–activity relationship studies on pregnane-type steroidal alkaloids that inhibit cholinesterases

Khalid, A., Ul‐Haq, Z., Anjum, S., Khan, M. R., Rahman, A., & Choudhary, M. I. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.03.002 · Cited by 59 · see citing works

Structure–activity relationships for inhibition of human cholinesterases by alkyl amide phenothiazine derivatives

Darvesh, S., McDonald, R. S., Penwell, A., Conrad, S., Darvesh, K. V., Mataija, D., Gomez, G., Caines, A., Walsh, R., & Martin, E. V. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.09.059 · Cited by 58 · see citing works

Onchidal: a naturally occurring irreversible inhibitor of acetylcholinesterase with a novel mechanism of action.

Abramson, S. N., Radić, Z., Manker, D. C., Faulkner, D. J., & Taylor, P. (1989) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09328-9 · Cited by 58 · see citing works

Synthetic approaches to carnegine, a simple tetrahydroisoquinoline alkaloid

Bracca, A. B. J., & Kaufman, T. S. (2004) · Tetrahedron · doi:10.1016/j.tet.2004.08.033 · Cited by 58 · see citing works

Bivalent Ligands Derived from Huperzine A as Acetylcholinesterase Inhibitors

Haviv, H., Wong, D. M., Silman, I., & Sussman, J. L. (2007) · Current Topics in Medicinal Chemistry · doi:10.2174/156802607779941215 · Cited by 56 · see citing works

Anticholinesterase Agents

Koelle, G. B., Volle, R. L., Holmstedt, B. R., Karczmar, A. G., & O'Brien, R. D. (1963) · Science · doi:10.1126/science.141.3575.63 · Cited by 56 · see citing works

Novel Anticholinesterases Based on the Molecular Skeletons of Furobenzofuran and Methanobenzodioxepine

Luo, W., Yu, Q., Zhan, M., Parrish, D. A., Deschamps, J. R., Kulkarni, S. S., Holloway, H. W., Alley, G. M., Lahiri, D. K., Brossi, A. R., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049309+ · Cited by 55 · see citing works

Selective Cholinesterase Inhibitory Activities of a New Monoterpene Diglycoside and Other Constituents from Nelumbo nucifera Stamens

Jung, H. A., Jung, Y. J., Hyun, S. K., Min, B.-S., Kim, D., Jung, J. H., & Choi, J. S. (2010) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.33.267 · Cited by 54 · see citing works

Search for dual function inhibitors for Alzheimer’s disease: Synthesis and biological activity of acetylcholinesterase inhibitors of pyridinium-type and their Aβ fibril formation inhibition capacity

Kapková, P., Alptüzün, V., Frey, P., Erciyas, E., & Holzgrabe, U. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.08.034 · Cited by 54 · see citing works

A novel anti-Alzheimer's disease drug, ladostigil

Weinreb, O., Amit, T., Bar‐Am, O., & Youdim, M. B. H. (2011) · International review of neurobiology · doi:10.1016/b978-0-12-386467-3.00010-8 · Cited by 52 · see citing works

New potential AChE inhibitor candidates

de Paula, A. A. N., Martins, J. B. L., dos Santos, M. L., Nascente, L. D. C., Romeiro, L. A. S., Areas, T. F. M. A., Vieira, K. S. T., Gambôa, N. F., Castro, N. G., & Gargano, R. (2009) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2009.03.045 · Cited by 52 · see citing works

Novel γ-secretase modulators for the treatment of Alzheimer's disease: a review focusing on patents from 2010 to 2012

Pettersson, M., Stepan, A. F., Kauffman, G. W., & Johnson, D. S. (2013) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2013.821465 · Cited by 51 · see citing works

Behring's discovery of diphtheria and tetanus antitoxins

Fj, G. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90125-q · Cited by 49 · see citing works

Synthesis and efficacy of 1-[bis(4-fluorophenyl)-methyl]piperazine derivatives for acetylcholinesterase inhibition, as a stimulant of central cholinergic neurotransmission in Alzheimer’s disease

Sadashiva, C. T., Chandra, J. N. N. S., Ponnappa, K. C., Gowda, T. V., & Rangappa, K. S. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.05.030 · Cited by 49 · see citing works

Spectroscopic studies on acetylcholinesterase: influence of peripheral-site occupation on active-center conformation

Berman, H. A., Becktel, W. J., & Taylor, P. (1981) · Biochemistry · doi:10.1021/bi00519a043 · Cited by 48 · see citing works

Structural Determinants of Torpedo c alifornica Acetylcholinesterase Inhibition by the Novel and Orally Active Carbamate Based Anti-Alzheimer Drug Ganstigmine (CHF-2819)

Bartolucci, C., Siotto, M., Ghidini, E., Amari, G., Bolzoni, P. T., Racchi, M., Villetti, G., Delcanale, M., & Lamba, D. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060293s · Cited by 47 · see citing works

Acetylcholinesterase inhibitory potential of a carbazole alkaloid, mahanimbine, from Murraya koenigii

Satheeshkumar, N., Mukherjee, P. K., Bhadra, S., Saha, B. P., & Pal, B. C. (2009) · Phytotherapy Research · doi:10.1002/ptr.3023 · Cited by 47 · see citing works

Inhibition of histamine versus acetylcholine metabolism as a mechanism of tacrine activity

Morisset‐Lopez, S., Traiffort, É., & Schwartz, J. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00738-8 · Cited by 46 · see citing works

Subacute Neurotoxicity Induced in Mice by Potent Organophosphorus Neuropathy Target Esterase Inhibitors

Wu, S., & Casida, J. E. (1996) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.0158 · Cited by 46 · see citing works

Synthesis, anticholinesterase activity and structure–Activity relationships of m-Aminobenzoic acid derivatives

Trujillo-Ferrara, J. G., Cano, L. M., & Espinoza-Fonseca, M. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00198-7 · Cited by 46 · see citing works

p–Aminobenzoic acid derivatives as acetylcholinesterase inhibitors

Correa‐Basurto, J., Alcántara, I. V., Espinoza-Fonseca, M., & Trujillo-Ferrara, J. G. (2005) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2005.03.011 · Cited by 44 · see citing works

Synthesis, Biological Activity, and Docking Studies of New Acetylcholinesterase Inhibitors of the Bispyridinium Type

Kapková, P., Stiefl, N., Sürig, U., Engels, B., Baumann, K., & Holzgrabe, U. (2003) · Archiv der Pharmazie · doi:10.1002/ardp.200300795 · Cited by 44 · see citing works

Molecular Docking Studies of Natural Cholinesterase-Inhibiting Steroidal Alkaloids from Sarcococca saligna

Ul‐Haq, Z., Wellenzohn, B., Liedl, K. R., & Rode, B. M. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0309194 · Cited by 43 · see citing works

Fluorescent phosphonate label for serine hydrolases, pyrenebutyl methylphosphonofluoridate: reaction with acetylcholinesterase

Berman, H. A., & Taylor, P. (1978) · Biochemistry · doi:10.1021/bi00602a019 · Cited by 43 · see citing works

Acetylcholinesterase Inhibitory Activity of Uleine from Himatanthus lancifolius

Seidl, C., Correia, B. L., Stinghen, A. E. M., & Santos, C. A. D. M. (2010) · Zeitschrift für Naturforschung C · doi:10.1515/znc-2010-7-804 · Cited by 43 · see citing works

Characterisation of the anticholinesterase activity of two new tacrine–huperzine A hybrids

Alcalá, M. D. M., Vivas, N. M., Camps, P., Muñoz‐Torrero, D., & Badı́a, A. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00071-6 · Cited by 43 · see citing works

Molecular recognition by acetylcholinesterase at the peripheral anionic site: structure–activity relationships for inhibitions by aryl carbamates

Lin, G., Lai, C., & Liao, W. (1999) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(99)00213-8 · Cited by 41 · see citing works

Preparation of secolycorines against acetylcholinesterase

Lee, S., Venkatesham, U., Rao, C. P., Lam, S.-H., & Lin, J. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.10.026 · Cited by 40 · see citing works

Central Cholinergic Agents. 6. Synthesis and Evaluation of 3-[1-(Phenylmethyl)-4-piperidinyl]-1-(2,3,4,5-tetrahydro-1H-1-benzazepin-8-yl)- 1-propanones and Their Analogs as Central Selective Acetylcholinesterase Inhibitors

Ishihara, Y., Hirai, K., Miyamoto, M., & Goto, G. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00041a007 · Cited by 40 · see citing works

Synthesis and cholinesterase activity of phenylcarbamates related to Rivastigmine, a therapeutic agent for Alzheimer's disease

Mustazza, C., Borioni, A., Giudice, M. R. D., GATTA, F., Ferretti, R., Meneguz, A., Volpe, M. T., & Lorenzini, P. (2002) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(01)01324-1 · Cited by 39 · see citing works

Inhibition of Butyrylcholinesterase Activity by Some Isoquinoline Alkaloids

Jitka Ulrichová, A., Walterová, D., Preininger, V., & Šimánek, V. (1983) · Planta Medica · doi:10.1055/s-2007-969916 · Cited by 39 · see citing works

Isoquinoline derivatives as potential acetylcholinesterase inhibitors

Markmee, S., Ruchirawat, S., Prachyawarakorn, V., Ingkaninan, K., & Khorana, N. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.01.067 · Cited by 39 · see citing works

A Study of the SORL1 Gene in Alzheimer's Disease and Cognitive Function

Liu, F., Ikram, M. A., Janssens, A. C. J. W., Schuur, M., de Koning, I., Isaacs, A. J., Struchalin, M. V., Uitterlinden, A. G., den Dunnen, J. T., Sleegers, K., et al. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1137 · Cited by 38 · see citing works

New potent human acetylcholinesterase inhibitors in the tetracyclic triterpene series with inhibitory potency on amyloid β aggregation

Rouleau, J., Iorga, B. I., & Guillou, C. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.02.073 · Cited by 38 · see citing works

Synthesis of physostigmine analogues and evaluation of their anticholinesterase activities

Zhan, Z., Bian, H.-L., Wang, J., & Shan, W. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.01.097 · Cited by 38 · see citing works

Isoprenoids in aging and neurodegeneration

Edlund, C., Söderberg, M. P., & Kristensson, K. (1994) · Neurochemistry International · doi:10.1016/0197-0186(94)90050-7 · Cited by 36 · see citing works

Synthesis and structure–activity relationships of open D-Ring galanthamine analogues

Herlem, D., Martin, M., Thal, C., & Guillou, C. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00397-4 · Cited by 34 · see citing works

Biological Mass Spectrometry. Basic Information on Nerve Gas and the Use of Sarin by Aum Shinrikyo. Plenary Lecture at the Biological Mass Spectrometry Conference Seto, Aichi, Japan July 3-6, 1995.

Tu, A. T. (1996) · Journal of the Mass Spectrometry Society of Japan · doi:10.5702/massspec.44.293 · Cited by 34 · see citing works

[13] Acetylcholinesterase

Rosenberry, T. L., Barnett, P., & Mays, C. (1982) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(82)82070-3 · Cited by 34 · see citing works

Prelude to the Discovery of Penicillin

Landsberg, H. (1949) · Isis · doi:10.1086/349043 · Cited by 32 · see citing works

Design, synthesis, and evaluation of benzophenone derivatives as novel acetylcholinesterase inhibitors

Belluti, F., Piazzi, L., Bisi, A., Gobbi, S., Bartolini, M., Cavalli, A., Valenti, P., & Rampa, A. (2008) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.02.035 · Cited by 32 · see citing works

Phenserine: a physostigmine derivative that is a long-acting inhibitor of cholinesterase and demonstrates a wide dose range for attenuating a scopolamine-induced learning impairment of rats in a 14-unit T-maze

Iijima, S., Greig, N. H., Garofalo, P., Spangler, E. L., Heller, B., Brossi, A. R., & Ingram, D. K. (1993) · Psychopharmacology · doi:10.1007/bf02244888 · Cited by 32 · see citing works

Terreulactone A, a novel meroterpenoid with anti-acetylcholinesterase activity from Aspergillus terreus

Kim, W., Cho, K., Lee, C., & Yoo, I. D. (2002) · Tetrahedron Letters · doi:10.1016/s0040-4039(02)00465-3 · Cited by 32 · see citing works

Amino acid sequence in the region of the reactive serine residue of eel acetylcholinesterase

Schaffer, N. K., Michel, H. O., & Bridges, A. F. (1973) · Biochemistry · doi:10.1021/bi00739a027 · Cited by 31 · see citing works

Latanoprost and Physostigmine Have Mostly Additive Ocular Hypotensive Effects in Human Eyes

Lindén, C. (1997) · Archives of Ophthalmology · doi:10.1001/archopht.1997.01100160027004 · Cited by 31 · see citing works

Antinociceptive Profile of (-)-Spectaline: A Piperidine Alkaloid fromCassia leptophylla

Alexandre‐Moreira, M. S., Viegas, C., Miranda, A. L. P., Bolzani, V. D. S., & Barreiro, E. J. (2003) · Planta Medica · doi:10.1055/s-2003-43201 · Cited by 29 · see citing works

Active site directed docking studies: Synthesis and pharmacological evaluation of cis-2,6-dimethyl piperidine sulfonamides as inhibitors of acetylcholinesterase

Girisha, H. R., Chandra, J. N. N. S., Boppana, S., Malviya, M., Sadashiva, C. T., & Rangappa, K. S. (2009) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2009.04.042 · Cited by 29 · see citing works

Oroxylin A analogs exhibited strong inhibitory activities against iNOS-mediated nitric oxide (NO) production

Pham, T.-A. N., Che, H., Phan, P.-T. T., Lee, J., Kim, S., & Park, H. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.01.135 · Cited by 29 · see citing works

Contemporary opinions about Mary Walker

Keesey, J. (1998) · Neurology · doi:10.1212/wnl.51.5.1433 · Cited by 29 · see citing works

The Crystal Structure of a Complex of Acetylcholinesterase with a Bis-(−)-nor-meptazinol Derivative Reveals Disruption of the Catalytic Triad

Paz, A., Xie, Q., Greenblatt, H. M., Fu, W., Tang, Y., Silman, I., Qiu, Z., & Sussman, J. L. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801657v · Cited by 28 · see citing works

Synthesis and Acetylcholinesterase/Butyrylcholinesterase Inhibition Activity of 4-Amino-2, 3-diaryl-5, 6, 7, 8-tetrahydrofuro(and thieno)[2, 3-b]-quinolines, and 4-Amino-5, 6, 7, 8, 9-pentahydro-2, 3-diphenylcyclohepta[e]furo(and thieno)-[2, 3-b]pyridines

Marco, J. L., Rı́os, C. D. L., Carreiras, M. C., Baños, J.-E., Badı́a, A., & Vivas, N. M. (2002) · Archiv der Pharmazie · doi:10.1002/1521-4184(200209)335:7 · Cited by 28 · see citing works

Stephaoxocanine, a Novel Dihydroisoquinoline Alkaloid from Stephania cepharantha

Kashiwaba, N., Morooka, S., Kimura, M., Ono, M., Toda, J., Suzuki, H., & Sano, T. (1996) · Journal of Natural Products · doi:10.1021/np960381n · Cited by 27 · see citing works

Reversible and irreversible inhibitory activity of succinic and maleic acid derivatives on acetylcholinesterase

Trujillo-Ferrara, J. G., Vázquez, I., Espinosa, J., Santillan, R. L., Farfán, N., & Herbert Höpfl, B. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(03)00023-x · Cited by 27 · see citing works

Eletefine, a Stephaoxocane Alkaloid from Cissampelos glaberrima

da Cunha, E. V. L., Cornélio, M. L., Barbosa‐Filho, J. M., Braz‐Filho, R., & Gray, A. I. (1998) · Journal of Natural Products · doi:10.1021/np980018b · Cited by 26 · see citing works

Isoterreulactone A, a novel meroterpenoid with anti-acetylcholinesterase activity produced by Aspergillus terreus

Yoo, I., Cho, K., Lee, C., & Kim, W. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.10.067 · Cited by 26 · see citing works

2-N-Methylexcentricine, a New Alkaloid from Roots of Stephania excentrica

Deng, J., & Zhao, S. (1997) · Journal of Natural Products · doi:10.1021/np960371m · Cited by 25 · see citing works

Multiple enzyme inhibitions by histamine H3 receptor antagonists as potential procognitive agents.

Petroianu, G. A., Arafat, K., Sasse, B. C., & Stark, H. (2006) · PubMed · Cited by 25 · see citing works

Chemical terrorism: a primer for 2002.

Goozner, B., Lutwick, L. I., & Bourke, E. (2002) · PubMed · Cited by 25 · see citing works

Biologic and chemical weapons of mass destruction

Bozeman, W. P., Dilbero, D., & Schauben, J. L. (2002) · Emergency Medicine Clinics of North America · doi:10.1016/s0733-8627(02)00037-8 · Cited by 24 · see citing works

Functional requirements for the optimal catalytic configuration of the AChE active center

Avigdor Shafferman, C., Barak, D., Kaplan, D., Ordentlich, A., Kronman, C., & Velan, B. (2005) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2005.10.021 · Cited by 21 · see citing works

Synthesis of tricyclic analogs of stephaoxocanidine and their evaluation as acetylcholinesterase inhibitors

Bianchi, D. A., Schmeda‐Hirschmann, G., Theoduloz, C., Bracca, A. B. J., & Kaufman, T. S. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.04.005 · Cited by 19 · see citing works

Synthesis and biological activity of pyridinium-type acetylcholinesterase inhibitors

Alptüzün, V., Kapková, P., Baumann, K., Erciyas, E., & Holzgrabe, U. (2003) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357021855 · Cited by 17 · see citing works

Inhibition of acetylcholinesterase from mammals and insects by carbofuran and its related compounds and their toxicities toward these animals

Yu, C., Metcalf, R. L., & Booth, G. M. (1972) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf60183a046 · Cited by 16 · see citing works

The Degenerative Dementias

Caselli, R. J., & Boeve, B. F. (2007) · Elsevier eBooks · doi:10.1016/b978-141603618-0.10033-5 · Cited by 16 · see citing works

Evaluation of a new lead for acetylcholinesterase inhibition

Khorana, N., Markmee, S., Ingkaninan, K., Ruchirawat, S., Kitbunnadaj, R., & Pullagurla, M. R. (2008) · Medicinal Chemistry Research · doi:10.1007/s00044-008-9122-3 · Cited by 15 · see citing works

Studies on Inhibitory Activity against Acetylcholinesterase of New Bisbenzylisoquinoline Alkaloid and Its Related Compounds

Ogino, T., Yamaguchi, T., Sato, T., Sasaki, H., Sugama, K., Okada, M., & Maruno, M. (1997) · Heterocycles · doi:10.3987/com-97-7935 · Cited by 15 · see citing works

A rate determining step change in the pre-steady state of acetylcholinesterase inhibitions by 1,n-alkane-di-N-butylcarbamates

Lin, G., Tseng, H.-C., Chio, A.-C., Tseng, T.-M., & Tsai, B.-Y. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.12.058 · Cited by 13 · see citing works

Alzheimer disease: The changing view

Breitner, J. C. S. (2001) · Annals of Neurology · doi:10.1002/ana.87 · Cited by 12 · see citing works

Current applied recombinant DNA projects

Gaertner, F., & Kim, L. (1988) · Trends in Ecology & Evolution · doi:10.1016/0169-5347(88)90128-0 · Cited by 9 · see citing works

The Influence of certain biological Factors on the Resistance of Bed-bugs (Cimex lectularius, L.) to DDT

Barnes, S. (1946) · Bulletin of Entomological Research · doi:10.1017/s0007485300024068 · Cited by 9 · see citing works

ChemInform Abstract: Central Cholinergic Agents. Part 6. Synthesis and Evaluation of 3‐(1‐( Phenylmethyl)‐4‐piperidinyl)‐1‐(2,3,4,5‐tetrahydro‐1H‐1‐benzazepin‐8‐ yl)‐1‐propanones and Their Analogues as Central Selective Acetylcholinesterase Inhibitors.

Ishihara, Y., Hirai, K., Miyamoto, M., & Goto, G. (1994) · ChemInform · doi:10.1002/chin.199451198 · Cited by 7 · see citing works

Ludwig Laqueur, MD (1839-1909)

SNYDER, C. (1964) · Archives of Ophthalmology · doi:10.1001/archopht.1964.00970020113023 · Cited by 3 · see citing works

Alzheimer disease: The changing view

Breitner, J. C. S. (2001) · Annals of Neurology · doi:10.1002/ana.87.abs · Cited by 3 · see citing works

Oxindole: A chemical prism carrying plethora of therapeutic benefits

Kaur, M., Singh, M., Chadha, N., & Silakari, O. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.08.011 · Cited by 350 · see citing works

Comprehensive review of mechanisms of pathogenesis involved in Alzheimer’s disease and potential therapeutic strategies

Sharma, P., Srivastava, P., Seth, A., Tripathi, P. N., Banerjee, A. G., & Shrivastava, S. K. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.12.006 · Cited by 331 · see citing works

Electrochemical Biosensors for Whole Blood Analysis: Recent Progress, Challenges, and Future Perspectives

Li, S., Zhang, H., Zhu, M. Z., Kuang, Z., Li, X., Xu, F., Miao, S., Zhang, Z., Lou, X., Li, H., et al. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00759 · Cited by 316 · see citing works

Molecular mechanisms underlying protective role of quercetin in attenuating Alzheimer's disease

Zaplatić, E., Bule, M. H., Shah, S. Z. A., Uddin, M. S., & Niaz, K. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.03.055 · Cited by 298 · see citing works

A critical review on the health benefits of fish consumption and its bioactive constituents

Chen, J., Jayachandran, M., Bai, W., & Xu, B. (2021) · Food Chemistry · doi:10.1016/j.foodchem.2021.130874 · Cited by 291 · see citing works

Organophosphate pesticide exposure and neurodegeneration

Sánchez-Santed, F., Colomina, M. T., & Hernández, E. H. (2015) · Cortex · doi:10.1016/j.cortex.2015.10.003 · Cited by 258 · see citing works

Neuroprotective Natural Products for Alzheimer’s Disease

Chen, X., Drew, J., Berney, W., & Lei, W. (2021) · Cells · doi:10.3390/cells10061309 · Cited by 236 · see citing works

Fluorescent Diagnostic Probes in Neurodegenerative Diseases

Zhou, J., Jangili, P., Son, S., Ji, M. S., Won, M., & Kim, J. S. (2020) · Advanced Materials · doi:10.1002/adma.202001945 · Cited by 206 · see citing works

The present and future of pharmacotherapy of Alzheimer's disease: a comprehensive review

Anand, A., Patience, A. A., Sharma, N., & Khurana, N. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.09.043 · Cited by 174 · see citing works

Neuroprotective Effect of Cardamom Oil Against Aluminum Induced Neurotoxicity in Rats

Auti, S. T., & Kulkarni, Y. A. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00399 · Cited by 145 · see citing works

Galantamine Slows Down Plaque Formation and Behavioral Decline in the 5XFAD Mouse Model of Alzheimer’s Disease

Bhattacharya, S., Haertel, C., Maelicke, A., & Montag, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089454 · Cited by 142 · see citing works

Recent Advances in Electrochemical Biosensors Based on Enzyme Inhibition for Clinical and Pharmaceutical Applications

Harrad, L. E., Bourais, I., Mohammadi, H., & Amine, A. (2018) · Sensors · doi:10.3390/s18010164 · Cited by 138 · see citing works

ApoE-Targeting Increases the Transfer of Solid Lipid Nanoparticles with Donepezil Cargo across a Culture Model of the Blood–Brain Barrier

Topal, G. R., Mészáros, M., Porkoláb, G., Szecskó, A., Polgár, T. F., Siklós, L., Deli, M. A., Veszelka, S., & Bozkır, A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics13010038 · Cited by 133 · see citing works

Traditional Chinese medicinal herbs as potential AChE inhibitors for anti-Alzheimer’s disease: A review

Jiang, Y., Gao, H., & Turdu, G. (2017) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2017.09.004 · Cited by 128 · see citing works

Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer’s disease (1998–2018)

Mishra, P., Kumar, A., & Panda, G. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.01.025 · Cited by 128 · see citing works

Neuroprotective role of astaxanthin in hippocampal insulin resistance induced by Aβ peptides in animal model of Alzheimer’s disease

Rahman, S. O., Panda, B. P., Parvez, S., Kaundal, M., Hussain, S., Akhtar, M., & Najmi, A. K. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.043 · Cited by 129 · see citing works

Acetylcholinesterase inhibitors (nerve agents) as weapons of mass destruction: History, mechanisms of action, and medical countermeasures

Aroniadou‐Anderjaska, V., Apland, J. P., Figueiredo, T. H., Furtado, M. D. A., & Braga, M. F. M. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108298 · Cited by 126 · see citing works

The current agonists and positive allosteric modulators of α7 nAChR for CNS indications in clinical trials

Yang, T., Xiao, T., Sun, Q. L., & Wang, K. (2017) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2017.09.001 · Cited by 121 · see citing works

An update on the novel and approved drugs for Alzheimer disease

Alhazmi, H. A., & Albratty, M. (2022) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2022.10.004 · Cited by 122 · see citing works

Benzenesulfonamide derivatives as potent acetylcholinesterase, α-glycosidase, and glutathione S-transferase inhibitors: biological evaluation and molecular docking studies

Taslımı, P., Işık, M., Türkan, F., Durgun, M., Türkeş, C., Gülçın, İ., & Beydemir, Ş. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1790422 · Cited by 115 · see citing works

Effects of food-derived bioactive peptides on cognitive deficits and memory decline in neurodegenerative diseases: A review

Wang, S., Sun‐Waterhouse, D., Waterhouse, G. I. N., Zheng, L. P., Su, G., & Zhao, M. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.04.056 · Cited by 111 · see citing works

Effects of Tea Catechins on Alzheimer’s Disease: Recent Updates and Perspectives

Ide, K., Matsuoka, N., Yamada, H., Furushima, D., & Kawakami, K. (2018) · Molecules · doi:10.3390/molecules23092357 · Cited by 103 · see citing works

An attempt to elucidate the role of iron and zinc ions in development of Alzheimer’s and Parkinson’s diseases

Wojtunik‐Kulesza, K. A., Oniszczuk, A., & Waksmundzka‐Hajnos, M. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.140 · Cited by 102 · see citing works

Success stories of natural product-based hybrid molecules for multi-factorial diseases

Choudhary, S., Singh, P. K., Verma, H., Singh, H., & Silakari, O. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.03.057 · Cited by 100 · see citing works

Therapeutic impact of grape leaves polyphenols on certain biochemical and neurological markers in AlCl3-induced Alzheimer’s disease

Borai, I. H., Ezz, M. K., Rizk, M. Z., Aly, H. F., El-Sherbiny, M., Matloub, A. A., & Fouad, G. I. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.07.038 · Cited by 98 · see citing works

Pinus halepensis essential oil attenuates the toxic Alzheimer’s amyloid beta (1-42)-induced memory impairment and oxidative stress in the rat hippocampus

Postu, P. A., Sadiki, F. Z., Idrissi, M. E., Cioancă, O., Trifan, A., Hăncianu, M., & Hriţcu, L. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108673 · Cited by 92 · see citing works

Characterization and Exploration of Potential Neuroprotective Peptides in Walnut ( Juglans regia ) Protein Hydrolysate against Cholinergic System Damage and Oxidative Stress in Scopolamine-Induced Cognitive and Memory Impairment Mice and Zebrafish

Wang, S., Su, G., Zhang, X., Song, G., Zhang, L., Zheng, L. P., & Zhao, M. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c07798 · Cited by 92 · see citing works

In Vitro Acetylcholinesterase-Inhibitory Properties of Enzymatic Hemp Seed Protein Hydrolysates

Malomo, S., & Aluko, R. (2016) · Journal of the American Oil Chemists Society · doi:10.1007/s11746-015-2779-0 · Cited by 77 · see citing works

SAR study to find optimal cholinesterase reactivator against organophosphorous nerve agents and pesticides

Górecki, L., Korábečný, J., Musílek, K., Maliňák, D., Nepovimová, E., Doležal, R., Jun, D., Soukup, O., & Kuča, K. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1827-3 · Cited by 89 · see citing works

Classics in Chemical Neuroscience: Donepezil

Brewster, J. T., Dell’Acqua, S., Thach, D. Q., & Sessler, J. L. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00517 · Cited by 91 · see citing works

Hybrids: a new paradigm to treat Alzheimer’s disease

Singh, M., Kaur, M., Chadha, N., & Silakari, O. (2015) · Molecular Diversity · doi:10.1007/s11030-015-9628-9 · Cited by 85 · see citing works

Design, synthesis and bioevaluation of tricyclic fused ring system as dual binding site acetylcholinesterase inhibitors

Tahir, S., Ramzan, M. S., Hassan, A., Sadiq, A., Jan, M. S., Khan, F. A., Ullah, F., Ahmad, H., Bibi, M., Mahmood, T., et al. (2018) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2018.10.035 · Cited by 84 · see citing works

Acetylcholinesterase Inhibitory Activities of Essential Oils from Vietnamese Traditional Medicinal Plants

Hùng, N. H., Quân, P. M., Satyal, P., Đài, Đ. N., Hoa, V. V., Ngo, G. H., An, N. T. G., Hà, N. T. T., Huong, L. T., Hien, V. T., et al. (2022) · Molecules · doi:10.3390/molecules27207092 · Cited by 84 · see citing works

Nootropic, neuroprotective and neurotrophic effects of phloretin in scopolamine induced amnesia in mice

Ghumatkar, P. J., Patil, S. P., Jain, P. D., Tambe, R., & Sathaye, S. S. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.06.005 · Cited by 84 · see citing works

Arylidene indanone scaffold: medicinal chemistry and structure–activity relationship view

Menezes, J. C. J. M. D. S. (2017) · RSC Advances · doi:10.1039/c6ra28613e · Cited by 83 · see citing works

A novel class of thiosemicarbazones show multi-functional activity for the treatment of Alzheimer's disease

Palanimuthu, D., Poon, R., Sahni, S., Anjum, R., Hibbs, D. E., Lin, H.-Y. J., Bernhardt, P. V., Kalinowski, D. S., & Richardson, D. R. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.08.021 · Cited by 81 · see citing works

Molecular docking and investigation of 4-(benzylideneamino)- and 4-(benzylamino)-benzenesulfonamide derivatives as potent AChE inhibitors

Işık, M., Demir, Y., Durgun, M., Türkeş, C., Necip, A., & Beydemir, Ş. (2019) · Chemical Papers · doi:10.1007/s11696-019-00988-3 · Cited by 77 · see citing works

Current pharmacotherapy and putative disease-modifying therapy for Alzheimer’s disease

Kulshreshtha, A., & Piplani, P. (2016) · Neurological Sciences · doi:10.1007/s10072-016-2625-7 · Cited by 75 · see citing works

Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer’s action: Design, synthesis, crystal structure and in-vitro biological evaluation

Manzoor, S., Prajapati, S. K., Majumdar, S., Raza, M. K., Gabr, M. T., Kumar, S., Pal, K., Rashid, H. U., Kumar, S., Krishnamurthy, S., et al. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113224 · Cited by 75 · see citing works

New tacrine dimers with antioxidant linkers as dual drugs: Anti-Alzheimer's and antiproliferative agents

Roldán-Peña, J. M., Alejandre-Ramos, D., López, Ó., Maya, I., Lagunes, I., Padrón, J. M., Peña‐Altamira, E., Bartolini, M., Monti, B., Bolognesi, M. L., et al. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.06.048 · Cited by 75 · see citing works

Blood–Brain Barrier Permeability Study of Potential Neuroprotective Compounds Recovered From Plants and Agri-Food by-Products

Sánchez-Martínez, J. D., Valdés, A., Gallego, R., Suárez-Montenegro, Z. J., Alarcón, M., Ibáñez, E., Álvarez‐Rivera, G., & Cifuentes, A. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.924596 · Cited by 79 · see citing works

Quinolone–benzylpiperidine derivatives as novel acetylcholinesterase inhibitor and antioxidant hybrids for Alzheimer Disease

Pudlo, M., Luzet, V., Ismaïli, L., Tomassoli, I., Iutzeler, A., & Refouvelet, B. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.02.046 · Cited by 73 · see citing works

Trigonelline insulates against oxidative stress, proinflammatory cytokines and restores BDNF levels in lipopolysaccharide induced cognitive impairment in adult mice

Chowdhury, A. A., Gawali, N. B., Munshi, R., & Juvekar, A. R. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-017-0147-5 · Cited by 74 · see citing works

Identification of a neuroprotective and selective butyrylcholinesterase inhibitor derived from the natural alkaloid evodiamine

Huang, G., Kling, B., Darras, F. H., Heilmann, J., & Decker, M. W. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.05.002 · Cited by 72 · see citing works

Neuroprotective effect of steroidal alkaloids on glutamate-induced toxicity by preserving mitochondrial membrane potential and reducing oxidative stress

Taveira, M., Sousa, C., Valentão, P., Ferreres, F., Teixeira, J. P., & Andrade, P. B. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.12.013 · Cited by 69 · see citing works

Acetylcholinesterase and butyrylcholinesterase inhibitory activities of khellactone coumarin derivatives isolated from Peucedanum japonicum Thurnberg

Heo, J. H., Eom, B. H., Ryu, H. W., Kang, M.-G., Park, J. E., Kim, D.-Y., Kim, J., Park, D., Oh, S., & Kim, H. (2020) · Scientific Reports · doi:10.1038/s41598-020-78782-5 · Cited by 68 · see citing works

Ameliorative Effect of Silymarin on Scopolamine-induced Dementia in Rats

El‐Marasy, S. A., Abd‐Elsalam, R. M., & Ahmed-Farid, O. A.-H. (2018) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2018.257 · Cited by 66 · see citing works

Cortical EEG oscillations and network connectivity as efficacy indices for assessing drugs with cognition enhancing potential

Ahnaou, A., Huysmans, H., Jacobs, T., & Drinkenburg, W. H. I. M. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.08.015 · Cited by 64 · see citing works

Evaluation of anti-amnesic effect of extracts of selected Ocimum species using in-vitro and in-vivo models

Singh, V., Kahol, A., Singh, I. P., Saraf, I., & Shri, R. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.10.026 · Cited by 64 · see citing works

Natural Peptides in Drug Discovery Targeting Acetylcholinesterase

Prasasty, V. D., Radifar, M., & Istyastono, E. P. (2018) · Molecules · doi:10.3390/molecules23092344 · Cited by 64 · see citing works

Mechanisms of Non-coenzyme Action of Thiamine: Protein Targets and Medical Significance

Aleshin, V. A., Mkrtchyan, G. V., & Bunik, V. I. (2019) · Biochemistry (Moscow) · doi:10.1134/s0006297919080017 · Cited by 61 · see citing works

Structure-based development of nitroxoline derivatives as potential multifunctional anti-Alzheimer agents

Knez, D., Brus, B., Coquelle, N., Sosič, I., Šink, R., Brazzolotto, X., Mravljak, J., Colletier, J., & Gobec, S. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.06.010 · Cited by 60 · see citing works

Isosteroidal alkaloids as potent dual-binding site inhibitors of both acetylcholinesterase and butyrylcholinesterase from the bulbs of Fritillaria walujewii

Liu, Y., Feng, Y.-D., Lu, X. L., Nie, J., Li, W., Wang, L., Tian, L.-J., & Liu, Q. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.06.007 · Cited by 58 · see citing works

Amine substitution of quinazolinones leads to selective nanomolar AChE inhibitors with ‘inverted’ binding mode

Darras, F. H., Wehle, S., Huang, G., Sotriffer, C., & Decker, M. W. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.06.045 · Cited by 58 · see citing works

Imperatorin ameliorates lipopolysaccharide induced memory deficit by mitigating proinflammatory cytokines, oxidative stress and modulating brain-derived neurotropic factor

Chowdhury, A. A., Gawali, N. B., Shinde, P., Munshi, R., & Juvekar, A. R. (2018) · Cytokine · doi:10.1016/j.cyto.2018.04.018 · Cited by 57 · see citing works

Volatile terpenoids as potential drug leads in Alzheimer’s disease

Wojtunik‐Kulesza, K. A., Targowska‐Duda, K. M., Klimek, K., Ginalska, G., Jóźwiak, K., Waksmundzka‐Hajnos, M., & Ciesla, L. M. (2017) · Open Chemistry · doi:10.1515/chem-2017-0040 · Cited by 55 · see citing works

Phytochemical Screening of Rosmarinus officinalis L. as a Potential Anticholinesterase and Antioxidant–Medicinal Plant for Cognitive Decline Disorders

Kamli, M. R., Sharaf, A. A. M., Sabir, J. S. M., & Rather, I. A. (2022) · Plants · doi:10.3390/plants11040514 · Cited by 55 · see citing works

Fat-soluble vitamins in patients with chronic pancreatitis (pancreatic insufficiency).

Nakamura, T., Takebe, K., Imamura, K., Tando, Y., Yamada, N., Arai, Y., Terada, A., Ishii, M., Kikuchi, H., & Suda, T. (1996) · PubMed · Cited by 52 · see citing works

Targeting Alzheimer's disease by investigating previously unexplored chemical space surrounding the cholinesterase inhibitor donepezil

van Greunen, D. G., Cordier, W., Nell, M. J., van der Westhuyzen, C. W., Steenkamp, V., Panayides, J., & Riley, D. L. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.10.036 · Cited by 51 · see citing works

Pyridones – Powerful Precursors for the Synthesis of Alkaloids, Their Derivatives, and Alkaloid-Inspired Compounds

Sośnicki, J. G., & Idzik, T. J. (2019) · Synthesis · doi:10.1055/s-0037-1611844 · Cited by 51 · see citing works

Combination of Omega 3 and Coenzyme Q10 Exerts Neuroprotective Potential Against Hypercholesterolemia-Induced Alzheimer's-Like Disease in Rats

Fouad, G. I. (2020) · Neurochemical Research · doi:10.1007/s11064-020-02996-2 · Cited by 50 · see citing works

Hybrid Quinoline-Thiosemicarbazone Therapeutics as a New Treatment Opportunity for Alzheimer’s Disease‒Synthesis, In Vitro Cholinesterase Inhibitory Potential and Computational Modeling Analysis

Zaib, S., Munir, R., Younas, M. T., Kausar, N., Ibrar, A., Aqsa, S., Shahid, N., Asif, T. T., Alsaab, H. O., & Khan, I. A. (2021) · Molecules · doi:10.3390/molecules26216573 · Cited by 49 · see citing works

Food‐derived Acetylcholinesterase Inhibitors as Potential Agents against Alzheimer’s Disease

Aluko, R. E. (2021) · eFood · doi:10.2991/efood.k.210318.001 · Cited by 48 · see citing works

Structure-based screening and molecular dynamics simulation studies for the identification of potential acetylcholinesterase inhibitors

Ganeshpurkar, A., Singh, R., Gore, P., Kumar, D., Gutti, G., Kumar, A., & Singh, S. K. (2019) · Molecular Simulation · doi:10.1080/08927022.2019.1682572 · Cited by 48 · see citing works

The Protective Effects of Gardenia jasminoides (Fructus Gardenia) on Amyloid-β-Induced Mouse Cognitive Impairment and Neurotoxicity

Zang, C., Bao, X.-Q., Li, L., Yang, H., Wang, L., Yu, Y., Wang, X., Yao, X., & Zhang, D. (2018) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x18500192 · Cited by 47 · see citing works

Synthesis and bio-evaluation of new multifunctional methylindolinone-1,2,3-triazole hybrids as anti-Alzheimer's agents

Saeedi, M., Maleki, A., Iraji, A., Hariri, R., Akbarzadeh, T., Edraki, N., Firuzi, O., & Mirfazli, S. S. (2020) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2020.129828 · Cited by 47 · see citing works

Novel inhibitors of AChE and Aβ aggregation with neuroprotective properties as lead compounds for the treatment of Alzheimer's disease

Liu, Y., Uras, G., Onuwaje, I., Li, W., Yao, H., Xu, S., Li, X., Li, X., Phillips, J. B., Allen, S., et al. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114305 · Cited by 46 · see citing works

Therapeutic Efficacies of Berberine against Neurological Disorders: An Update of Pharmacological Effects and Mechanisms

Shou, J., & Shaw, P. (2022) · Cells · doi:10.3390/cells11050796 · Cited by 46 · see citing works

Amaryllidaceae alkaloids with new framework types from Zephyranthes candida as potent acetylcholinesterase inhibitors

Zhan, G., Liu, J., Zhou, J., Sun, B., Aisa, H. A., & Yao, G. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.10.057 · Cited by 45 · see citing works

Recent Advances in Multi-target Anti-Alzheimer Disease Compounds (2013 Up to the Present)

Wang, N., Qiu, P., Cui, W., Yan, X., Zhang, B., & He, S. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867326666181203124102 · Cited by 45 · see citing works

Plant‐derived bioactive peptides: A comprehensive review

Kadam, D., Kadam, A., Köksel, F., & Aluko, R. E. (2024) · Sustainable Food Proteins · doi:10.1002/sfp2.1036 · Cited by 44 · see citing works

Enzymes as Diagnostic Tools

Singh, R. S., Singh, T., & Singh, A. K. (2019) · Elsevier eBooks · doi:10.1016/b978-0-444-64114-4.00009-1 · Cited by 44 · see citing works

Potential of flavonoids as anti-Alzheimer’s agents: bench to bedside

Kaur, R., Sood, A., Lang, D. K., Bhatia, S., Al‐Harrasi, A., Aleya, L., & Behl, T. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-18165-z · Cited by 44 · see citing works

Molecular Insights into Therapeutic Potentials of Hybrid Compounds Targeting Alzheimer’s Disease

Jana, A., Bhattacharjee, A., Das, S. S., Srivastava, A., Choudhury, A., Bhattacharjee, R., De, S., Perveen, A., Iqbal, D., Gupta, P. K., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02779-6 · Cited by 44 · see citing works

Arginine-Containing Peptides Derived from Walnut Protein Against Cognitive and Memory Impairment in Scopolamine-Induced Zebrafish: Design, Release, and Neuroprotection

Wang, S., Su, G., Fan, J., Xiao, Z., Zheng, L. P., Zhao, M., & Wu, J. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c05104 · Cited by 43 · see citing works

Discorhabdin alkaloids from Antarctic Latrunculia spp. sponges as a new class of cholinesterase inhibitors

Botić, T., Defant, A., Zanini, P., Žužek, M. C., Frangež, R., Janussen, D., Kersken, D., Knez, Ž., Mancini, I., & Sepčić, K. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.05.019 · Cited by 43 · see citing works

Therapeutic Effects of Natural Drugs on Alzheimer’s Disease

Ma, Y., Yang, M., Li, X., Yue, J.-W., Chen, J., Yang, M.-W., Huang, X., Zhu, L., Hong, F., & Yang, S. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01355 · Cited by 43 · see citing works

Synthesis, characterization, biological evaluation, and kinetic study of indole base sulfonamide derivatives as acetylcholinesterase inhibitors in search of potent anti-Alzheimer agent

Taha, M., Alshamrani, F., Rahim, F., Anouar, E. H., Uddin, N., Chigurupati, S., Almandil, N. B., Farooq, R. K., Iqbal, N., Aldubayan, M. A., et al. (2021) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2021.101401 · Cited by 43 · see citing works

Highly sensitive and rapid detection of acetylcholine using an ITO plate modified with platinum-graphene nanoparticles

Chauhan, N., Narang, J., & Jain, U. (2015) · The Analyst · doi:10.1039/c4an01873g · Cited by 42 · see citing works

Exosomes as a potential messenger unit during heterochronic parabiosis for amelioration of Huntington's disease

Lee, M., Im, W., & Kim, M. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105374 · Cited by 42 · see citing works

Gene Therapy for Huntington’s Disease: The Final Strategy for a Cure?

Byun, S., Lee, M., & Kim, M. (2021) · Journal of Movement Disorders · doi:10.14802/jmd.21006 · Cited by 40 · see citing works

Synthesis, docking and biological evaluation of oxamide and fumaramide analogs as potential AChE and BuChE inhibitors

Yerdelen, K. Ö., & Tosun, E. (2014) · Medicinal Chemistry Research · doi:10.1007/s00044-014-1152-4 · Cited by 40 · see citing works

Acetylcholinesterase and butyrylcholinesterase inhibitory activities of antioxidant peptides obtained from enzymatic pea protein hydrolysates and their ultrafiltration peptide fractions

Asen, N. D., & Aluko, R. E. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14289 · Cited by 39 · see citing works

Nasal Application of the Galantamine Pro-drug Memogain Slows Down Plaque Deposition and Ameliorates Behavior in 5X Familial Alzheimer’s Disease Mice

Bhattacharya, S., Maelicke, A., & Montag, D. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142421 · Cited by 39 · see citing works

Synthesis and biological evaluation of 3-arylcoumarins as potential anti-Alzheimer's disease agents

Yang, J. W., Zhang, P., Hu, Y., Liu, T., Sun, J., & Wang, X. (2019) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2019.1574297 · Cited by 39 · see citing works

Kinetics of acetylcholinesterase inhibition by hemp seed protein‐derived peptides

Malomo, S. A., & Aluko, R. E. (2019) · Journal of Food Biochemistry · doi:10.1111/jfbc.12897 · Cited by 42 · see citing works

Anti-Alzheimer’s Disease Activity of Bromophenols from a Red Alga, Symphyocladia latiuscula (Harvey) Yamada

Paudel, P., Seong, S. H., Zhou, Y., Park, H. J., Jung, H. A., & Choi, J. S. (2019) · ACS Omega · doi:10.1021/acsomega.9b01557 · Cited by 40 · see citing works

Aptamer-functionalized magnetic nanoparticles conjugated organic framework for immobilization of acetylcholinesterase and its application in inhibitors screening

Zhao, L., Yang, G. H., Li, L., Zhu, C., Ma, Y., & Qu, F. (2020) · Analytica Chimica Acta · doi:10.1016/j.aca.2020.10.024 · Cited by 38 · see citing works

Does the application of acetylcholinesterase inhibitors in the treatment of Alzheimer’s disease lead to depression?

Mitić, M., & Lazarević-Pašti, T. (2021) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2021.1931681 · Cited by 31 · see citing works

In vitro antiglycating effect and in vivo neuroprotective activity of Trigonelline in d -galactose induced cognitive impairment

Chowdhury, A. A., Gawali, N. B., Bulani, V. D., Kothavade, P. S., Mestry, S. N., Deshpande, P. S., & Juvekar, A. R. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.09.006 · Cited by 37 · see citing works

Sensitive biosensing of neurotransmitter: 2D material wrapped nanotubes and MnO2 composites for the detection of acetylcholine

Chauhan, N., Balayan, S., & Jain, U. (2020) · Synthetic Metals · doi:10.1016/j.synthmet.2020.116354 · Cited by 37 · see citing works

New 3,5-dimethylorsellinic acid-based meroterpenoids with BACE1 and AchE inhibitory activities from Aspergillus terreus

Qi, C., Qiao, Y., Gao, W., Liu, M., Zhou, Q. Y., Chen, C., Lai, Y., Xue, Y., Zhang, J., Li, D., et al. (2018) · Organic & Biomolecular Chemistry · doi:10.1039/c8ob02741b · Cited by 36 · see citing works

Novel N-benzylpiperidine carboxamide derivatives as potential cholinesterase inhibitors for the treatment of Alzheimer's disease

van Greunen, D. G., van der Westhuizen, C. J., Cordier, W., Nell, M. J., Stander, A., Steenkamp, V., Panayides, J., & Riley, D. L. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.06.088 · Cited by 36 · see citing works

Rat hormone sensitive lipase inhibition by cyclipostins and their analogs

Vasilieva, E., Dutta, S., Malla, R. K., Martin, B. P., Spilling, C. D., & Dupureur, C. M. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.01.028 · Cited by 34 · see citing works

Design, synthesis and biological evaluation of novel 2-phenyl-1-benzopyran-4-one derivatives as potential poly-functional anti-Alzheimer's agents

Singh, M., & Silakari, O. (2016) · RSC Advances · doi:10.1039/c6ra17678j · Cited by 34 · see citing works

2-Arylbenzofurans from Artocarpus lakoocha and methyl ether analogs with potent cholinesterase inhibitory activity

Namdaung, U., Athipornchai, A., Khammee, T., Kuno, M., & Suksamrarn, S. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.10.019 · Cited by 34 · see citing works

Diet therapy for the treatment of Alzheimer's disease in view of traditional Persian medicine: A review.

Iranshahy, M., & Javadi, B. (2019) · PubMed Central · doi:10.22038/ijbms.2019.36505.8694 · Cited by 34 · see citing works

Butyrylcholinesterase inhibitors as potential anti-Alzheimer’s agents: an updated patent review (2018-present)

Fernández‐Bolaños, J. G., & López, Ó. (2022) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2022.2083956 · Cited by 35 · see citing works

Design, Synthesis, DFT, Molecular Docking, and Biological Evalution of Pyrazole Derivatives as Potent Acetyl Cholinestrease Inhibitors

Abdelwahab, H. E., Ibrahim, H. Z., & Omar, A. Z. (2022) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2022.134137 · Cited by 34 · see citing works

ChemInform Abstract: Acetylcholinesterase Inhibitors as Alzheimer Therapy: From Nerve Toxins to Neuroprotection

Singh, M., Kaur, M., Kukreja, H., Chugh, R., Silakari, O., & Singh, D. (2014) · ChemInform · doi:10.1002/chin.201410271 · Cited by 1 · see citing works

Potent Acetylcholinesterase Inhibitors: Potential Drugs for Alzheimer’s Disease

Akıncıoğlu, H., & Gülçın, İ. (2020) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557520666200103100521 · Cited by 158 · see citing works

Mechanisms of Neuroprotective Effects of Therapeutic Acetylcholinesterase Inhibitors Used in Treatment of Alzheimer′s Disease

Takada‐Takatori, Y. (2006) · ChemInform · doi:10.1002/chin.200652272

Research Progress of Acetylcholinesterase Inhibitors in the Treatment of Alzheimer’s Disease

Jiang, Y. (2012) · Guangzhou Chemistry · Cited by 2 · see citing works

Natural acetylcholinesterase inhibitors: A multi-targeted therapeutic potential in Alzheimer's disease

Kumar, G., K., P. G., Poornima, D. V., Shantaram, M., & Ranjita, G. (2024) · European Journal of Medicinal Chemistry Reports · doi:10.1016/j.ejmcr.2024.100154 · Cited by 88 · see citing works